Cytopathological alterations and therapeutic approaches in Binswanger's disease

Neuropathology

Volumn 19, Issue 1, 1999, Pages 119-128

  Akiguchi, I ^a   Tomimoto, H ^a   Wakita, H ^a   Yamamoto, Y ^a   Suenaga, T ^a   Ueno, M ^a   Budka, H ^a  

^a KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Ambulatory blood pressure monitoring; Axon; Binswanger's disease; Blood brain barrier dysfunction; Coagulation activation; Glia; Immunohistochemistry

Indexed keywords

ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; ARGATROBAN; COMPLEMENT; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; FIBRINOGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PENTOXIFYLLINE; PROSTANOID; TACROLIMUS; THROMBIN;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BINSWANGER ENCEPHALOPATHY; BLOOD BRAIN BARRIER; BLOOD CLOTTING; BLOOD PRESSURE MONITORING; BRAIN EDEMA; BRAIN INJURY; BRAIN MICROCIRCULATION; BRAIN VENTRICLE; CYTOPATHOLOGY; GLIA CELL; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MYELIN SHEATH; NERVE FIBER; NONHUMAN; PARENCHYMA; PATIENT CARE; PERFUSION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; WHITE MATTER;

EID: 0032991639     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.1999.00208.x     Document Type: Article

References (56)

1. 1 Roman GC. From UBOs to Binswanger's disease: Impact of magnetic resonance imaging on vascular dementia research. Stroke 1996 ; 27: 1269–1273.
2. 2 Tatemichi TK, Foulkes MA, Mohr JP et al. Dementia in stroke survivors in the Stroke Data Bank cohort: prevalence, incidence, risk factors, and computed tomographic findings. Stroke 1990 ; 21: 858–866.
3. 3 Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology 1995 ; 45: 1161–1168.
4. 4 Tomonaga M, Yamanouchi H, Tohgi H, Kameyama M. Clinicopathological study of progressive subcortical encephalopathy (Binswanger type) in the elderly. J Am Geriatr Soc 1982 ; 30: 524–529.
5. 5 Bennett DA, Silson RS, Gilley DW, Fox JH. Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry 1990 ; 53: 961–965.
6. 6 Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992 ; 42: 473–480.
7. 7 Caplan LR & Schoene WC. Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger's disease). Neurology 1978 ; 28: 1206–1215.
8. 8 Caplan LR. Binswanger's disease revisited. Neurology 1995 ; 45: 626–633.
9. 9 Brun A & Englund E. A white matter disorder in dementia of the Alzheimer's type: A pathoanatomical study. Ann Neurol 1986 ; 19: 253–262.
10. 10 Kawamura J, Meyer JS, Terayama Y, Weathers S. Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 1991 ; 22: 609–614.
11. 11 Stewart PA, Hayakawa K, Akers MA, Vinters HV. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tom‐ographic scan (leuko‐araiosis). Arch Neurol 1987 ; 44: 36–39.
12. 12 Longstreth WT, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The cardiovascular health study. Stroke 1996 ; 27: 1274– 1282.
13. 13 Suenaga T, Ohnishi K, Nishimura M, Nakamura S, Akiguchi I, Kimura J. Bundles of amyloid precursor protein‐immunoreactive axons in human cerebrovas‐cular white matter lesions. Acta Neuopathol (Berl) 1994 ; 87: 450–455.
14. 14 Tomimoto H, Akiguchi I, Suenaga T et al. Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions. Acta Neuropathol (Berl) 1995 ; 90: 608–614.
15. 15 Tomimoto H, Akiguchi I, Suenaga T et al. Alterations of the blood–brain barrier and glial cells in white matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 1996 ; 27: 2069–2074.
16. 16 Tomimoto H, Akiguchi I, Suenaga T et al. Regressive change of astroglia in white matter lesions in cere‐brovascular and Alzheimer's disease patients. Acta Neuropathol (Berl) 1997 ; 94: 146–152. DOI: 10.1007/s004010050686
17. 17 Tomimoto H, Akiguchi I, Akiyama H, Kimura J, Yanagihara T. T cell infiltration and expression of MHC class II antigen by macrophage/microglia in a heter‐ogeneous group of leukoencephalopathy. Am J Pathol 1993 ; 143: 579–586.
18. 18 Akiguchi I, Tomimoto H, Wakita H et al. Alterations of glial cells in Binswanger's type infarction and ex‐perimental chronic cerebral hypoperfusion. Brain Pathol 1994 ; 4: 506.
19. 19 Englund E & Brun A. White matter changes in dementia of Alzheimer's type: The difference in vulnerability between cell compartments. Histopathology 1990 ; 16: 433–439.
20. 20 Yamanouchi H, Sugiura S, Tomonaga M. Decrease in nerve fibers in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type: An electron microscopic study. J Neurol 1989 ; 236: 382–387. DOI: 10.1007/BF00314894
21. 21 Roman GC. Senile dementia of Binswanger type: A vascular form of dementia in the elderly. JAMA 1987 ; 258: 1782–1788. DOI: 10.1001/jama.258.13.1782
22. 22 Mast H, Tatemichi TK, Mohr JP. Chronic brain ischemia: The contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular demen‐tia. J Neurol Sci 1995 ; 132: 4–10. DOI: 10.1016/0022-510X(95)00116-J
23. 23 Yao H, Sadoshima S, Ibayashi S, Kuwabara Y, Ichiya Y, Fujishima M. Leukoaraiosis and dementia in hyper‐tensive patients. Stroke 1992 ; 23: 1673–1677.
24. 24 Kuwabara Y, Ichiya Y, Otsuka M, Masuda K, Ichimiya A, Fujishima M. Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type. Stroke 1992 ; 23: 594–598.
25. 25 Feigin I & Popoff N. Neuropathological changes late in cerebral edema: The relationship to trauma, hypertensive disease and Binswanger's encephalopathy. J Neuropathol Exp Neurol 1963 ; 22: 500–511.
26. 26 Tohgi H, Abe T, Takahashi S, Kikuchi T. The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer‐type dementia and Parkinson's disease. J Neural Transm Park Dis Dement Sect 1993 ; 6: 119–126.
27. 27 Alafuzoff I, Adolfsson R, Bucht G, Winblad B. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi‐infarct dementia. J Neurol Sci 1983 ; 60: 465– 472. DOI: 10.1016/0022-510X(83)90157-0
28. 28 Ma KC, Lundberg PO, Lilja A, Olsson Y. Binswanger's disease in the absence of chronic arterial hypertension: A case report with clinical, radiological and immuno‐histochemical observations on intracerebral blood vessels. Acta Neuropathol (Berl) 1992 ; 83: 434–439. DOI: 10.1007/BF00713538
29. 29 Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Blood–brain barrier dysfunction in Binswanger's disease: An immunohistochemical study. Acta Neuropathol (Berl) 1998 ; 95: 78–84. DOI: 10.1007/s004010050768
30. 30 Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Alterations of glia and axons in the brains of Binswanger's disease patients. Stroke 1997 ; 28: 1423–1429.
31. 31 Wakita H, Tomimoto H, Akiguchi I, Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: An im‐munohistochemical study. Acta Neuropathol (Berl) 1994 ; 87: 484–492.
32. 32 Wakita H, Tomimoto H, Akiguchi I, Kimura J. Protective effect of cyclosporin A on the white matter changes in the rat after chronic cerebral hypoperfusion. Stroke 1995 ; 26: 1415–1422.
33. 33 Wakita H, Tomimoto H, Akiguchi I, Kimura J. Dose‐dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res 1998 ; 792: 105–113. DOI: 10.1016/S0006-8993(98)00126-7
34. 34 Akiguchi I, Tomimoto H, Wakita H, Osaki A, Kimura J, Yamamoto Y. Increased coagulatory activity in subcortical arteriosclerotic encephalopathy (Binswanger's disease). J Neurol (in press).
35. 35 Kario K, Kodama K, Koide M, Matsuo T. Thrombin inhibition in the acute phase of ischemic stroke using argatroban. Blood Coagul Fibrinolysis 1995 ; 6: 423–427.
36. 36 Akiguchi I, Tomimoto H, Kinoshita M et al. Effects of antithrombin in Binswanger's disease with antiphos‐pholipid antibody syndrome. Neurology (in press).
37. 37 Akiguchi I, Murase N, Satoi H, Kaji R, Tomimoto H, Kanda M. Familial Binswanger‐type encephalopathy with Sneddon syndrome. Cerebrovasc Dis 1996 ; 6 1: 68.
38. 38 Yamamoto Y, Akiguchi I, Oiwa K, Satoi S, Kimura J. Leukoaraiosis and multiple lacunar infarct from the stand point of 24‐hour blood pressure monitoring (in Japanese with English abstract). Jpn J Stroke 1993 ; 15: 353–359.
39. 39 Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Kimura J. Adverse effect of night‐time blood pressure on the outcome of lacunar infarct patients. Stroke 1998 ; 29: 570–576.
40. 40 Akiguchi I, Horie R, Yamori Y, Kameyama M. Lethal course of stroke and therapeutic effects in strokeprone spontaneously hypertensive rats. In: Yamori Y, Lovenberg W (eds). Prophylactic Approach to Hyper‐tensive Diseases. New York: Raven Press, 1979 ; 185–194.
41. 41 Hazama F, Yamada E, Yukioka N. Blood–brain barrier dysfunction as a pathogenetic factor in chronic hyper‐tensive lesions. In: Johansson BB, Owman CH, Widner H (eds). Pathophysiology of the Blood–Brain Barrier. Amsterdam: Elsevier, 1990 ; 297–301.
42. 42 Akiguchi I, Yagi H, Shimada A et al. Neuropathological studies on strains of senescence accelerated mouse with age related deficits in learning and memory. In: Hanin I, Yoshida M (eds). Alzheimer's and Parkinson's Disease. Advances in Behavioral Biology, Vol. 44. New York: Plenum Press, 1995: 395–400.
43. 43 Ueno M, Akiguchi I, Hosokawa M et al. Accumulation of blood borne horseradish peroxidase in medial portions of the mouse hippocampus. Acta Neurol Scand 1994 ; 90: 400–404.
44. 44 Ueno M, Akiguchi I, Hosokawa M et al. Age‐related changes in the brain transfer of blood‐borne horsera‐dish peroxidase in the hippocampus of senescence‐accelerated mouse (SAM). Acta Neuropathol (Berl) 1997 ; 93: 233–240. DOI: 10.1007/s004010050609
45. 45 Ueno M, Akiguchi I, Hosokawa M et al. Ultrastructural and permeability features of microvessels in the olfac‐tory bulbus of SAM mice. Acta Neuropathol (Berl) 1998 ; 96: 261–270. DOI: 10.1007/s004010050893
46. 46 Thomas WS, Mori E, Copeland BR, Yu JQ, Morrissey JH, Del Zoppo GJ. Tissue factor contributes to mic‐rovascular defects after focal cerebral ischemia. Stroke 1993 ; 24: 847–853.
47. 47 Nishino A, Suzuki M, Yoshimoto T, Otani H, Nagura H. A novel aspect of thrombin in the tissue reaction following central nervous system injury. Acta Neurochir 1994 ; 60 1: 86–88.
48. 48 Tomimoto H, Akiguchi I, Wakita H et al. Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol (Berl) 1996 ; 92: 281–287. DOI: 10.1007/s004010050519
49. 49 Sairanen T, Ristimaki A, Karjalainen Lindsberg ML, Paetau A, Kaste M, Lindsberg PJ. Cyclooxygenase‐2 is induced globally in infarcted human brain. Ann Neurol 1998 ; 43: 738–747. DOI: 10.1002/ana.410430608
50. 50 Miyamoto K, Oka N, Kawasaki T, Satoi H, Akiguchi I, Kimura J. The effect of cyclooxygenase‐2 inhibitor on experimental allergic neuritis. Neuroreport 1998 ; 9: 2331–2334.
51. 51 Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke 1995 ; 26: 52–56.
52. 52 Tomimoto H, Akiguchi I, Wakita H et al. Coagulation activation in Binswanger's disease patients. Arch Neurol (in press).
53. 53 Okeda R. Morphometrische verleichsuntersuchungen an hirnarterien bei Binswangerscher encephalopathie und hochdruckencephalopathie (in German with English abstract). Acta Neuropathol (Berl) 1973 ; 26: 23–43. DOI: 10.1007/BF00685521
54. 54 Furuta A, Ishii N, Nishihara Y, Horie A. Medullary arteries in aging and dementia. Stroke 1991 ; 22: 442– 446.
55. 55 Yamamoto Y, Akiguchi I, Oiwa K, Satoi H, Kimura J. Diminished nocturnal blood pressure decline and lesion site in cerebrovascular disease. Stroke 1995 ; 26: 829–833.
56. 56 Yamamoto Y & Akiguchi I. Ambulatory blood pressure in lacunar infarct patients: Response. Stroke 1998 ; 29: 1740–1742.